ClinicalTrials.govpublic full text
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
diabetes mellitus, type 2, urosepsis, diabetic ketoacidosis, lower extremity amputation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 398295
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.